Literature DB >> 18622142

Predictive factors of attrition in a cohort of Alzheimer disease patients. The REAL.FR study.

Nicola Coley1, Virginie Gardette, Olivier Toulza, Sophie Gillette-Guyonnet, Christelle Cantet, Fati Nourhashemi, Sandrine Andrieu, Alain Grand, Bruno Vellas.   

Abstract

BACKGROUND: Attrition, i.e. patient dropout, can threaten the validity of results in longitudinal studies. The aim of this study was to identify patient and caregiver factors predictive of attrition in a cohort of Alzheimer disease (AD) patients.
METHODS: 686 patients with mild to moderate AD were included in the multicenter prospective REAL.FR study. Standardized gerontological evaluations were carried out twice yearly. Factors associated with attrition were assessed by survival analysis using a Cox proportional hazard model.
RESULTS: After 2 years, 278 (40.5%) patients had dropped out. Causes of attrition included refusal (20.9%), death (20.1%), institutionalization (19.8%), and loss to follow-up (19.8%). Attrition rates between each 6-month wave were constant at 12%. After adjustment, several independent factors remained associated with attrition: patients cared for by an unrelated caregiver [HR 1.7; 95% CI (1.08-2.59)], loss of autonomy [HR = 1.37; (1.03-1.82)], increasing caregiver burden [HR = 1.014; (1.005-1.022)], use of cholinesterase inhibitors [HR = 0.40; (0.27-0.59)], use of 1 to 3 other types of medication [HR = 0.57; (0.36-0.89)].
CONCLUSIONS: The identification of both patient and caregiver factors predictive of attrition is of particular interest for the development and targeting of attrition prevention strategies. In patients with chronic diseases, particular attention should be paid to caregiver well-being to limit attrition. Copyright 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2008        PMID: 18622142     DOI: 10.1159/000144087

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  16 in total

1.  Incidence and predictive factors of depressive symptoms in Alzheimer's disease: the REAL.FR study.

Authors:  C Arbus; V Gardette; C E Cantet; S Andrieu; F Nourhashémi; L Schmitt; B Vellas
Journal:  J Nutr Health Aging       Date:  2011-08       Impact factor: 4.075

2.  Factors influencing attrition in 35 Alzheimer's Disease Centers across the USA: a longitudinal examination of the National Alzheimer's Coordinating Center's Uniform Data Set.

Authors:  Shanna L Burke; Tianyan Hu; Mitra Naseh; Nicole M Fava; Janice O'Driscoll; Daniel Alvarez; Linda B Cottler; Ranjan Duara
Journal:  Aging Clin Exp Res       Date:  2018-12-10       Impact factor: 3.636

3.  Retention of Alzheimer Disease Research Participants.

Authors:  Joshua D Grill; Jimmy Kwon; Merilee A Teylan; Aimee Pierce; Eric D Vidoni; Jeffrey M Burns; Allison Lindauer; Joseph Quinn; Jeff Kaye; Daniel L Gillen; Bin Nan
Journal:  Alzheimer Dis Assoc Disord       Date:  2019 Oct-Dec       Impact factor: 2.703

4.  Predictive factors of discontinuation and switch of cholinesterase inhibitors in community-dwelling patients with Alzheimer's disease: a 2-year prospective, multicentre, cohort study.

Authors:  Virginie Gardette; Sandrine Andrieu; Maryse Lapeyre-Mestre; Nicola Coley; Christelle Cantet; Pierre-Jean Ousset; Alain Grand; Jean-Louis Monstastruc; Bruno Vellas
Journal:  CNS Drugs       Date:  2010-05       Impact factor: 5.749

5.  Diabetes, Heart Disease, and Dementia: National Estimates of Functional Disability Trajectories.

Authors:  Janet L MacNeil Vroomen; Ling Han; Joan K Monin; Kasia J Lipska; Heather G Allore
Journal:  J Am Geriatr Soc       Date:  2018-03-09       Impact factor: 5.562

6.  Challenging Assumptions About African American Participation in Alzheimer Disease Trials.

Authors:  Richard E Kennedy; Gary R Cutter; Guoqiao Wang; Lon S Schneider
Journal:  Am J Geriatr Psychiatry       Date:  2017-04-25       Impact factor: 4.105

7.  Retaining Participants in Outpatient and Community-Based Health Studies: Researchers and Participants in Their Own Words.

Authors:  Donna H Odierna; Lisa A Bero
Journal:  Sage Open       Date:  2014

8.  Statistical Considerations for Embedded Pragmatic Clinical Trials in People Living with Dementia.

Authors:  Heather G Allore; Keith S Goldfeld; Roee Gutman; Fan Li; Joan K Monin; Monica Taljaard; Thomas G Travison
Journal:  J Am Geriatr Soc       Date:  2020-07       Impact factor: 5.562

9.  Near-infrared spectroscopy (NIRS) and vagus somatosensory evoked potentials (VSEP) in the early diagnosis of Alzheimer's disease: rationale, design, methods, and first baseline data of the Vogel study.

Authors:  Thomas Polak; Martin J Herrmann; Laura D Müller; Julia B M Zeller; Andrea Katzorke; Matthias Fischer; Fabian Spielmann; Erik Weinmann; Leif Hommers; Martin Lauer; Andreas J Fallgatter; Jürgen Deckert
Journal:  J Neural Transm (Vienna)       Date:  2017-09-01       Impact factor: 3.575

10.  Assessing generalisability through the use of disease registers: findings from a diabetes cohort study.

Authors:  Michael David; Robert Ware; Maria Donald; Rosa Alati
Journal:  BMJ Open       Date:  2011-08-27       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.